Graybug Vision procures $80 mln Series C

Silicon Valley-based Graybug Vision Inc, a clinical stage pharmaceutical company, has secured $80 million in Series C financing. CBC Group led the round with participation from other investors that included Deerfield Management, OrbiMed Advisors and Hatteras Venture Partners.

North AmericaUSHealthcareBriefs